Novo Nordisk is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical companies next week. CEO Lars Jørgensen told reporters Thurs ...
The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.The report is built to visualize ...
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...
Teladoc Health (TDOC) announced a pharmacy integration agreement with Eli Lilly’s (LLY) LillyDirect pharmacy partner, Gifthealth, which will ...
MarketBeat on MSN6h
Eli Lilly Pours $27B Into U.S. Growth-What It Means for InvestorsWhatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...
Novo Nordisk A/S (NVO) has lowered prices of its blockbuster drug Wegovy for U.S. customers through a new direct-to-consumer online pharmacy, ...
DelveInsight's Biosensors Market Insights report provides the current and forecast market analysis, individual leading biosensors ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback